![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-6697|14|4|385-390
ISSN: 1573-4099
Source: Current Computer - Aided Drug Design, Vol.14, Iss.4, 2018-12, pp. : 385-390
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tadalafil: First report of migraine aura: case report
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Paterna Salvatore Pasquale Pietro Cottone Carlo Seidita Gregorio Cardinale Antonella Parrinello Gaspare Ferrari Giovanni Licata Giuseppe
Cardiovascular Drugs and Therapy, Vol. 11, Iss. 4, 1997-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Diclofenac plus caffeine may be effective for the acute treatment of migraine without aura
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 3, 2015-04 ,pp. :